NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVERS DISEASES AND ATHEROSCLEROSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14391929

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

5-cholesten, 3β, 25-diol, disulfate (25HCDS) has been found to be an authentic PPARγ agonist and LXR antagonist, and is used for the therapy of lipid disorders and inflammatory diseases, including without limitation fatty liver, inflammatory bowel, and atherosclerotic diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS810 VERMONT AVENUE NW WASHINGTON DC 20420
VIRGINIA COMMONWEALTH UNIVERSITY800 EAST LEIGH STREET SUITE 3000 RICHMOND VA 23298

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ren, Shunlin Redmond, US 37 128

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation